Amity University confers honorary doctorate on Thumbay Moideen

coastaldigest.com news network
November 21, 2017

Dubai, Nov 21: Thumbay Moideen, the Founder President of Dubai-based global conglomerate Thumbay Group, was conferred an Honorary Doctorate at the annual convocation ceremony of Amity University – Dubai, on November 20. Mr. Moideen, the Guest of Honour of the convocation ceremony, was awarded the doctorate in the presence of distinguished dignitaries, academicians, students, teachers and parents.

An official statement by Amity University Dubai said that Mr.ThumbayMoideen was being conferred the honor in view of his “significant contributions towards promotion of medical education, trade and industry, and social and economic development of the nation.”

In his acceptance speech, Mr. Thumbay Moideen expressed his gratitude to Amity University Dubai for awardingthe doctorate. “Throughout my career, I have had the privilege of transforming lives through education and healthcare, strengthening communities and contributing to the growth and progress of the nation. I owe my success to God Almighty, the support of the government, and my team. This recognition will inspire me to do more in driving positive change,” he said.

Mr. Thumbay Moideen awarded certificates to the graduates and the honors for batch toppers.

About Mr. Thumbay Moideen

Mr. ThumbayMoideen is the Founder President of Thumbay Group, a diversified international conglomerate headquartered at DIFC - Dubai, United Arab Emirates (UAE). Starting with the establishment of Thumbay Group in 1998, he has set up business operations in 20 sectors. Today, the Group has activities in Education, Healthcare, Medical Research, Diagnostics, Retail Pharmacy, Health Communications, Retail Optical, Wellness, Nutrition Stores, Hospitality, Real Estate, Publishing, Technology, Media, Events, Medical Tourism, Trading and Marketing & Distribution.

Thumbay Group today employs close to 5000 people, which is projected to increase to around 25000 by the year 2022, with the completion of ongoing and upcoming projects. The Thumbay chain of hospitals, the constituent teaching hospitals of the Gulf Medical University are one of the largest healthcare services providers in the UAE, serving patients from over 175 nationalities. The Gulf Medical University (GMU) which is one of the leading private medical universities in the Middle East region, attracts a student cohort of 80 nationalities and faculty and staff from over 25 countries. Currently, Thumbay Group is focusing on its strategic long-term plans which will see the group scale its businesses almost ten times and expand its operations globally.

The Group plans to build three more international campuses in the next five years. This is in addition to the plans to expand the chain of academic hospitals to 15 worldwide by 2022, with a total capacity of 1000 beds in the UAE, 1500 beds in India and 750 beds elsewhere in the Gulf and in Africa. The group also plans to expand specialized retail outlets.

Comments

ABDUL SALAM BELMA
 - 
Wednesday, 22 Nov 2017

All the best, congrats to well deserved person

Ahmed Bava
 - 
Tuesday, 21 Nov 2017

Masha Allah Mabrook Mr.Moideen Thumbay

AR Shetty
 - 
Tuesday, 21 Nov 2017

Hearty Congratulations saab

Muhammed Ali Uchil
 - 
Tuesday, 21 Nov 2017

Great honor-A Doctorate from World reputed Amity University-

thanks for  choosing the  right and most deserved person for 

this Privilege .

 

Heartily Congratulations Moideen Saab.

Danish
 - 
Tuesday, 21 Nov 2017

Wow. great! All the best for your future ventures..

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 7,2020

Mangaluru, May 7: The Dakshina Kannada District Muslim Okkoota has strongly condemned permit for opening of textile and footwear shops across the district at a time when the number of Covid-19 positive cases are on the rise.

In a press note here on Thursday, former Mayor and Okoota President Ashraf alleged that the permission to open the shops at a time when Eid-ul-Fitr was nearing would lead to rush in the shops in turn bringing in fear of spread of Covid-19. 

He expressed his resentment over the fact that the administration has neglected the appeal made by the Okkoota as well as the Qazi of Udupi against permitting textile shops during the lockdown period.

He warned that the administration, district in-charge Minister, MLA and MP themselves will be responsible in case of increased infection cases due to this decision.

The district in-charge minister Kota Srinivas Poojary yesterday had announced that textile shops in the district can be opened from May 7.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 9,2020

Bengaluru, Jul 9: The total number of Covid-19 infections in Karnataka on Thursday breached the 30,000 mark as the state reported its biggest single-day spike of over 2,200 new cases and 17 related fatalities, taking the death toll to 486, the Health department said.

The day also saw a record 957 patients getting discharged after recovery, out of which 606 were from Bengaluru Urban.

Out of the 2,228 fresh cases reported on Thursday, a whopping 1,373 were from Bengaluru Urban alone.

The previous biggest single-day spike was recorded on July 8 with 2,062 cases.

As of July 9 evening, cumulatively 31,105 Covid-19 positive cases have been confirmed in the state, which includes 486 deaths and 12,833 discharges, the Health department said in its bulletin.

It said, out of 17,782 active cases, 17,325 patients are in isolation at designated hospitals and are stable, while 457 are in ICU.

"Death rate in Karnataka is 1.49 percent, while in Bengaluru is 1.28 percent, and our target is to bring it below 1 percent," Medical Education Minister K Sudhakar told reporters.

"The reason for spike in cases in Bengaluru and other places in recent days is because during the last four months of lockdown we had controlled it very well, but as we relaxed lockdown for economic activities we did not follow certain precautionary measures like distance among other things," he said.

The Minister also conceded that there were lapses on part of the government also in terms of tracing and tracking.

"It has to be improved especially in Bengaluru and we are taking steps in this regard."

Among the 17 dead seven were from Dharwad, two each from Hassan, Kalaburagi, Mysuru, and one each from Raichur, Uttara Kannada, Tumakuru and Davangere.

The deceased include 13 men and 4 women.

The dead are all either with a history of Severe Acute Respiratory Infection (SARI) or Influenza-like illness (ILI).

Out of 2,228 fresh cases today, contacts of the majority of the cases are still under tracing.

Among the districts where the new cases were reported, Bengaluru Urban accounted for 1,373, followed by Dakshina Kannada (167), Kalaburagi (85) and Dharwad (75).

Bengaluru urban district tops the list of positive cases, with a total of 13,882 infections, followed by Kalaburagi (1,901) and Dakshina Kannada 1,701.

Among discharges Bengaluru urban tops the list with total 2,834, followed by Kalabuagi (1,392) and Udupi (1,206).

A total of 7,79,209 samples were tested so far, out of which 20,028 were tested on Thursday alone.

So far 7,28,887 samples have been reported as negative, and of them 17,568 were reported negative today.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.